Carcinoma Renal Cell clinical trials

Explore recruiting carcinoma renal cell clinical trials.

Recruiting carcinoma renal cell studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Carcinoma Renal Cell trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporous magnesium carbonate (DPH001) compared to Nexavar® (sorafenib) in healthy volunteers

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporous magnesium carbonate (DPH001) compared to Nexavar® (sorafenib) in healthy volunteers

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

A study to investigate the safety and tolerability of intravenous QEQ278 in patients with advanced solid tumors

France, Italy, Germany, Belgium, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1b, Open-Label, Dose-Escalation Trial of the Safety of and Antigen-Specific Immune Responses Elicited by VB.10 NEO in Combination With Atezolizumab in Subjects with Locally Advanced and Metastatic Tumors

Germany, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Carcinoma Renal Cell trials by city

Carcinoma Renal Cell clinical trials

Recruiting carcinoma renal cell studies right now

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

CARE1 Pragmatic Clinical Trial

Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer

A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Rein 3D PRINT PERSONALIZE

Also recruiting in Europe

An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporous magnesium carbonate (DPH001) compared to Nexavar® (sorafenib) in healthy volunteers

An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporous magnesium carbonate (DPH001) compared to Nexavar® (sorafenib) in healthy volunteers

A study to investigate the safety and tolerability of intravenous QEQ278 in patients with advanced solid tumors

A Phase 1b, Open-Label, Dose-Escalation Trial of the Safety of and Antigen-Specific Immune Responses Elicited by VB.10 NEO in Combination With Atezolizumab in Subjects with Locally Advanced and Metastatic Tumors

Carcinoma Renal Cell trials by city

Other conditions